1. Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy
   Ajaz A. Bhat et al, 2022, Cancer Communications CrossRef
2. Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy
   Astrid Z. Johansen et al, 2023, Frontiers in Immunology CrossRef
3. Polymethoxylated flavone sudachitin is a safe anticancer adjuvant that targets glycolysis in cancer‑associated fibroblasts
   Shuhai Chen et al, 2022, Oncology Letters CrossRef
4. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
   Hao Zhang et al, 2023, Molecular Cancer CrossRef
5. Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
   Ji Eun Yu et al, 2024, Experimental & Molecular Medicine CrossRef
6. Stromal cells in the tumor microenvironment: accomplices of tumor progression?
   Yan Zhao et al, 2023, Cell Death & Disease CrossRef
7. Chemokine systems in oncology: From microenvironment modulation to nanocarrier innovations
   Meng Guan et al, 2024, International Journal of Biological Macromolecules CrossRef
8. Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers
   Deyao Zhao et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
9. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
   Richard E. Kast et al, 2022, Cancers CrossRef
10. Cancer-Associated Fibroblasts and Their Role in Cancer Progression
    Lukáš Lacina et al, 2022, Cancer Research: An Interdisciplinary Approach CrossRef
11. Complement factor I knockdown inhibits colon cancer development by affecting Wnt/β-catenin/c-Myc signaling pathway and glycolysis
    Yong-Jun Du et al, 2024, World Journal of Gastrointestinal Oncology CrossRef
12. Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker
    Chiara Bazzichetto et al, 2022, Biomedicines CrossRef
13. Targeting the devil: Strategies against cancer-associated fibroblasts in colorectal cancer
    Yuting Chen et al, 2024, Translational Research CrossRef
14. Integrated analysis of fibroblasts molecular features in papillary thyroid cancer combining single-cell and bulk RNA sequencing technology
    Wei Li et al, 2022, Frontiers in Endocrinology CrossRef
15. Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights
    Kuan-Jung Chiu et al, 2022, Biomedicines CrossRef
16. Potential Roles and Future Perspectives of Chitinase 3-like 1 in Macrophage Polarization and the Development of Diseases
    Hailong Zhao et al, 2023, International Journal of Molecular Sciences CrossRef
17. Colorectal Liver Metastasis: Can Cytokines Make the Difference?
    Costanza Ballarò et al, 2023, Cancers CrossRef
18. Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis
    Mengrui Yang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
19. JP1 normalizes tumor vasculature to suppress metastasis and facilitate drug delivery by inhibiting IL-8
    Jiahua Cui et al, 2023, JCI Insight CrossRef
20. Thymoquinone affects hypoxia-inducible factor-1α expression in pancreatic cancer cells via HSP90 and PI3K/AKT/mTOR pathways
    Zhan-Xue Zhao et al, 2024, World Journal of Gastroenterology CrossRef
21. Fully human chitinase-3 like-1 monoclonal antibody inhibits tumor growth, fibrosis, angiogenesis, and immune cell remodeling in lung, pancreatic, and colorectal cancers
    Pei-Chia Su et al, 2024, Biomedicine & Pharmacotherapy CrossRef